Management of Communicating Hydrocephalus

Introduction to Management

The American Heart Association recommends that the definitive management of communicating hydrocephalus requires cerebrospinal fluid (CSF) diversion through either temporary measures for acute cases or permanent shunting for chronic cases, based on the clinical presentation and underlying etiology 1, 2

The American Heart Association suggests that acute symptomatic communicating hydrocephalus should be managed by CSF diversion using external ventricular drainage (EVD) or lumbar drainage, depending on the clinical scenario 1, 2
For patients with subarachnoid hemorrhage (SAH)-associated hydrocephalus, EVD placement is generally associated with neurological improvement 1
Weaning EVD over >24 hours does not appear to be effective in reducing the need for ventricular shunting and should not be routinely performed 1, 2

The American Heart Association recommends that chronic symptomatic communicating hydrocephalus should be treated with permanent CSF diversion (ventriculoperitoneal, ventriculoatrial, or lumboperitoneal shunts) 1, 2, 3
Chronic shunt-dependent hydrocephalus occurs in 8.9% to 48% of patients with SAH 1
Factors associated with the need for permanent CSF diversion include older age, early ventriculomegaly, intraventricular hemorrhage, poor clinical condition on presentation, and female sex 3

For posthemorrhagic hydrocephalus (PHH) in premature infants, several temporary surgical options exist, including ventricular access devices (VADs), external ventricular drains (EVDs), ventriculosubgaleal (VSG) shunts, and lumbar punctures (LPs) 4, 5
VSG shunts reduce the need for daily CSF aspiration compared with VADs in premature infants 4, 5
The routine use of serial lumbar puncture is not recommended to reduce the need for shunt placement or to avoid the progression of hydrocephalus in premature infants 4, 5

Intraventricular thrombolytic agents including tissue plasminogen activator (tPA), urokinase, or streptokinase are not recommended to reduce the need for shunt placement in premature infants with PHH 4, 5
Acetazolamide and furosemide are not recommended as methods to reduce the need for shunt placement in premature infants with PHH 4, 5

Contrast-enhanced MRI is recommended to evaluate for hydrocephalus and distinguish between communicating and non-communicating types 6
Ventriculomegaly (not from cerebral atrophy) and transependymal edema are hallmarks of acute hydrocephalus 6, 7
Lumbar puncture with measurement of opening pressure can help diagnose communicating hydrocephalus 6, 7

There is no specific weight or CSF parameter to direct the timing of shunt placement in premature infants with PHH; clinical judgment is required 4, 5
When hydrocephalus is secondary to another condition (infection, hemorrhage, tumor), the underlying cause should also be addressed 7

Patients presenting with communicating hydrocephalus who exhibit acute neurological decline—such as decreased consciousness, signs of transtentorial herniation, or rapidly progressive deterioration—should be identified as urgent cases requiring immediate intervention. 8, 9
In pediatric patients, routine measurement of occipitofrontal head circumference and assessment for developmental delay are recommended to detect early hydrocephalus progression. 10, 11

For infants, bedside cranial ultrasound can be employed to monitor ventricular size; hydrocephalus is defined when the atrium exceeds 10 mm on a horizontal plane or the body of the lateral ventricle exceeds 10 mm at the level of the thalamus. 10, 11

Immediate cerebrospinal fluid (CSF) diversion (e.g., external ventricular drainage or lumbar drainage) is indicated for patients with communicating hydrocephalus who develop decreased consciousness, clinical herniation, or markedly elevated intracranial pressure. 8, 9
Selection of the diversion modality (external ventricular drain versus lumbar drain) should be tailored to the individual clinical scenario. 8

In premature infants with post‑hemorrhagic communicating hydrocephalus, temporizing strategies—including ventricular access devices, external ventricular drains, ventriculo‑subgaleal shunts, or lumbar punctures—are employed while clinical judgment determines the optimal timing for definitive shunt placement. 11
Ventriculo‑subgaleal shunts have been shown to decrease the frequency of daily CSF aspiration compared with ventricular access devices. 11
Serial lumbar puncture is not recommended as a routine measure to reduce the need for shunt placement or to halt hydrocephalus progression; this recommendation is supported by Level I evidence. 11

Current evidence is insufficient to endorse specific changes in ventricular dimensions as a reliable marker of treatment effectiveness; this is a Level III recommendation. 12
Successful clinical response to shunting or endoscopic third ventriculostomy does not require demonstrable reduction in ventricular size. 12
Post‑treatment ventricular volume may remain stable or show modest decline, but such imaging findings do not predict long‑term neurological outcome. 12

When communicating hydrocephalus occurs as a complication of bacterial meningitis, placement of an external ventricular drain is indicated to address obstructive hydrocephalus. 13
In awake, monitorable patients with communicating hydrocephalus, invasive options such as repetitive lumbar puncture or external lumbar drainage may be considered, although they are not routinely required. 13